Hospital News and Research

RSS

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.

1 Nov 2010

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.

1 Nov 2010

HealthAlliance of the Hudson Valley to implement REACH3's CRM solution

REACH3 - healthcare CRM's market leader, enabling robust provider and payer marketing initiatives through secure, cloud-based technology - announced today that HealthAlliance of the Hudson Valley has chosen to implement its CRM Custom solution to strengthen its consumer and patient marketing campaigns, as well as enhance the unified brand identity of its newly formed health system.

1 Nov 2010

LHC Group enters joint venture with Rockcastle Regional Hospital and Respiratory Care Center

LHC Group, Inc., a national provider of home health and hospice, announced today that it has entered into a home health joint venture with Rockcastle Regional Hospital and Respiratory Care Center, located in Mount Vernon, Kentucky to provide home health services in Rockcastle County in the Certificate of Need (CON) state of Kentucky.

1 Nov 2010

Nycomed acquires majority stake in Guangdong Techpool Bio-Pharma

Nycomed today announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool), a fast-growing Chinese bio-pharmaceutical company based in Guangdong. Techpool, founded in 1993, specialises in the research, development, manufacturing and marketing of biologic drugs derived from natural sources.

1 Nov 2010

McKesson to acquire US Oncology

McKesson Corporation, a leading healthcare services and information technology company, and US Oncology, a leading integrated oncology company, announced today that the two companies have signed a definitive agreement under which McKesson will purchase all outstanding shares of US Oncology for cash.

1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

First Edition: November 1, 2010

In today's health policy headlines, how will Tuesday's election impact the health law?

1 Nov 2010

American Anesthesiology acquires Greensboro Anesthesia Physicians

American Anesthesiology, a subsidiary of MEDNAX, Inc., today announced the acquisition of Greensboro Anesthesia Physicians, P.C., a physician group practice that provides patient services at three hospitals within the Moses Cone Health System and two surgery centers in the Greensboro, NC, metropolitan area.

1 Nov 2010

Seven tips for navigating Medicare maze

If you're about to turn 65, you'll be part of the first wave of baby boomers signing up for Medicare. Consumer Reports Health recommends signing up as early as three months ahead of your birthday. Failing to do so could potentially cost you thousands of dollars down the road. That's one of seven tips for navigating the Medicare maze available in the December issue of Consumer Reports and online at www.ConsumerReportsHealth.org.

1 Nov 2010

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Oncimmune® LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, today announced that two oral presentations and five poster presentations during this week's American College of Chest Physicians' (ACCP) annual meeting in Vancouver will collectively highlight the clinical and economic benefits of EarlyCDT-Lung.

1 Nov 2010

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

Researchers are calling for clear guidelines on childhood stroke after a study, published in the November issue of Acta Paediatrica, found wide variations in time lag to diagnosis, investigation and treatment.

1 Nov 2010

Integra LifeSciences signs multi-year contract with The Broadlane Group

Integra LifeSciences Holdings Corporation announced today that it has signed a multi-year contract with The Broadlane Group to provide dural repair, neuro trauma (neuro critical care), and hydrocephalus products and accessories to its client hospitals.

1 Nov 2010

Vertex reports superior SVR rates with telaprevir-based combination therapy in Phase 3 studies for hepatitis C

Vertex Pharmaceuticals Incorporated today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have not been treated previously. In these studies, the majority of people achieved superior sustained viral response (SVR or viral cure) rates with a telaprevir-based combination regimen, compared to current therapies, regardless of race/ethnicity or stage of liver fibrosis (factors known to limit response to current hepatitis C treatments).

1 Nov 2010

Shield signs strategic commercialization agreement for ST10-021 iron therapy product

Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has signed a strategic commercialisation agreement for its lead asset, ST10-021, an iron therapy product which has commenced Phase III clinical development, with AOP Orphan Pharmaceuticals AG.

1 Nov 2010

Intentional foreign body ingestion results in over $2 million hospital costs: Study

A new study from Rhode Island Hospital found that 33 individuals were responsible for 305 cases of medical intervention to remove foreign bodies that were intentionally swallowed, resulting in more than $2 million in estimated hospital costs. The findings appear in the November issue of Clinical Gastroenterology and Hepatology.

1 Nov 2010

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.

1 Nov 2010

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

Researchers have found that allergic infants may be at increased risk of peanut allergy if their mothers ingested peanuts during pregnancy. The data are reported in the November 1, 2010 issue of the Journal of Allergy and Clinical Immunology.

1 Nov 2010

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

1 Nov 2010

Child Life Program organizes Halloween celebration for children undergoing treatment

Once a year cartoon characters, fairy princesses and action heroes gather at St. Jude Children's Research Hospital as hundreds of employees work together to turn the hospital into a giant trick-or-treat trail for children battling cancer and other catastrophic diseases. The event spans buildings and floors throughout the campus in Memphis, Tenn.

1 Nov 2010

Hospital News and Research

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

HealthAlliance of the Hudson Valley to implement REACH3's CRM solution

LHC Group enters joint venture with Rockcastle Regional Hospital and Respiratory Care Center

Nycomed acquires majority stake in Guangdong Techpool Bio-Pharma

McKesson to acquire US Oncology

Vascular Pathways closes $14 million Series B equity financing round

First Edition: November 1, 2010

American Anesthesiology acquires Greensboro Anesthesia Physicians

Seven tips for navigating Medicare maze

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

Integra LifeSciences signs multi-year contract with The Broadlane Group

Vertex reports superior SVR rates with telaprevir-based combination therapy in Phase 3 studies for hepatitis C

Shield signs strategic commercialization agreement for ST10-021 iron therapy product

Intentional foreign body ingestion results in over $2 million hospital costs: Study

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

New PHQ-9 screening test evaluates major depression in adults

Child Life Program organizes Halloween celebration for children undergoing treatment

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News